REFERENCES
S. Vikulova, Remedium, No. 12, 30–32 (1999).
K. G. Gurevich and A. P. Meshkovskii, Farmateka, No. 6, 12–16 (2001).
WHO Expert Committee on Specifications for Pharmaceuticals. The 34th Report (WHO Report Series, No. 863), WHO, Geneva (1998).
European Pharmacopoeia, 4th Edition (2002).
“FIP guidelines for dissolution testing of solid oral products (final draft, 1995). Joint report of the section for official laboratories and medicines control services and the section of industrial pharmacists, ” Drug Information J., 30, 1071–1084 (1996).
Guidance for Industry. Dissolution Testing of Immediate Release Solid Oral Dosage Forms.–Office of Training and Communications. Division of Communications Management the Drug Information Branch, HFD-210, 5600 Fishers Lane Rockville, MD 20857 (1997).
Pharmacopoeia of the United States. The National Formulary. USP XXVI (2003).
R. Espinoza, E. Hong, and L. Villafuerte, Int. J. Pharm., 201, 165–173 (2000).
P. Nykanen, S. Lempää, and M.-L. Aaltonen, Int. J. Pharm., 229, 155–162 (2001).
N. Zerrouk, C. Chemtob, P. Arnaud, et al., Int. J. Pharm., 225, 49–62 (2001).
British Pharmacopoeia (2002).
Japanese Pharmacopoea XIV (2001).
General Pharmacopoeial Article, OFS 42–0003–00: Dissolution, Moscow (2000).
I. J. McGilveray, Drug Inform. J., 30, 1029–1037 (1996).
S. A. Qureshi, Drug Inform. J., 30, 1055–1061 (1996).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Arzamastsev, A.P., Sadchikova, N.P. & Luttseva, T.Y. A Comparative Analysis of Requirements to the Pharmacopoeial Drug Dissolution Test. Pharmaceutical Chemistry Journal 37, 37–43 (2003). https://doi.org/10.1023/A:1023655230101
Issue Date:
DOI: https://doi.org/10.1023/A:1023655230101